Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces a new combination to support healthy liver function, LivLonga®, giving a boost to a category teeming with dated, generic products.
- Details
- Press Release
- Details
- Press Release
Sabinsa is pleased to announce that several of the company’s ingredients have been Non-GMO Project Verified, adding to the value the end-user finds in Sabinsa’s transparency and commitment to natural, sustainable, and Non-GMO ingredients.
- Details
- Press Release
Sabinsa’s Curcumin C3 Complex®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine®, on serum cytokine concentrations. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial was published in the peer-reviewed journal Phytotherapy Research.
- Details
- Press Release
Sabinsa founder and chairman Dr. Muhammed Majeed presents check to PM CARES Fund.
From Left to Right: Ms. Neeraja Shetty, CEO and Director, Sami Labs; Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group; Dr. Anju Majeed, Director and Sr. Scientist, Sami Labs; and Shaheen Majeed, President Worldwide, Sabinsa and Director, Sami Labs
- Details
- Press Release
Material Claiming Naturally High Amounts of Vitamin C IRMS-Tested, Establishing It as Non-Amla, Fermentation Source
Sabinsa, which alerted the industry to synthetic curcumin masquerading as natural source turmeric, has identified mischaracterized amla (Emblica officinalis) extract with claims of high levels of natural vitamin C for sale in the marketplace.